Stockreport

TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

TriSalus Life Sciences, Inc.  (TLSI) 
PDF Company delivers 42% revenue growth year-over-year and strengthens balance sheet with $22 million gross proceeds from recent private placementExpands commercial footprin [Read more]